Both in Pharmaceuticals
Damora Therapeutics vs Nektar Therapeutics
Over the past year DMRA returned −23.1% and NKTR returned −44.7%; their daily moves had a correlation of 0.42.
DMRA −23.1% NKTR −44.7%Growth of $1, one year, split-adjusted
| Metric | DMRA | NKTR |
|---|---|---|
| Price | $21.61 | $38.55 |
| Market cap | $1.33B | $1.32B |
| Today | −1.59% | +1.53% |
| 1 month | +4.6% | −34.9% |
| 6 months | — | −53.7% |
| Year to date | — | −8.8% |
| 1 year | — | −38.4% |
| Revenue growth (YoY) | — | −9.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −401.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 24.1× |
| Net cash | $540.5M | $684.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 69.9% |
| Short % of float | 11.2% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).